TrialDrug design, development and therapy2023

Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects.

Xu Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.